Company profile
UK company 07188244, incorporated on 12 March 2010.
Ig Innovations Limited is a UK company with status active founded in 2010 based in South East England.
Company number 07188244
Updated 07 Jul 2026 09:49
Reference milestones and recent Companies House filing stream events.
TM01 | Transaction MzU0MzEzODMzMmFkaXF6a2N4
Published 08 Sep 2026 14:03
AA | Transaction MzU0MDUzNTc3N2FkaXF6a2N4 | Paper/PDF filed
Published 02 Sep 2026 22:56
Company registered at Companies House
1 Jul 2012 to 30 Jun 2015
A simple, easy to use, rapid, inexpensive, effective, point of care (POC) immunodiagnostic system for early confirmation of sepsis in at-risk patients is to be developed and validated. The biomarkers will include IL-6, C-reactive protein and soluble ICAM-1. These known biomarkers will be integrated via a new algorithm with other physical/clinical indicato...
1 Sep 2011 to 31 Dec 2013
Benefiting from over 15 years extensive research, this collaboration between MaimoniDex, Mologic Ltd, Ig Innovations and Swansea University Medical School is working to develop a new biomarker for early diagnosis and confirmation of rheumatoid arthritis. MaimoniDex has identified a CDD44 isoform termed CD44vRA as a potential therapeutic target. The collab...
